Association of Cerebral Venous Thrombosis with mRNA COVID-19 Vaccines: A Disproportionality Analysis of the World Health Organization Pharmacovigilance Database

Jin Park, Moo-Seok Park, Hyung Jun Kim, Tae-Jin Song

Cerebral venous thrombosis (CVT), a rare thrombotic event that can cause serious neurologic deficits, has been reported after some ChAdOx1 nCoV-19 vaccinations against coronavirus disease 2019 (COVID-19). However, there are few reports of associations between COVID-19 mRNA vaccination and CVT. We retrospectively analyzed CVT occurrence, time of onset after vaccination, outcomes (recovered/not recovered), and death after COVID-19 vaccination from adverse drug reactions (ADR) reports in VigiBase. A disproportionality analysis was performed regarding COVID-19 mRNA vaccines (BNT162b2 and mRNA-1273) and the ChAdOx1 nCoV-19 vaccine … We noted a potential safety signal for CVT occurrence after COVID-19 mRNA vaccination. Therefore, awareness about the risk of CVT, even after COVID-19 mRNA vaccination, is necessary.

Latest articles

Madhava Setty Primum non nocere, “first and foremost, I will do no...
Emily Kopp and Karolina Corin A team of Western virologists could face...
privacyisyourright.ca Using the declaration of a pandemic as an excuse, the CPSO...
Aric Cox Many of you have been on protocol, after protocol, after...
Jeffrey Jaxen Talking to the news host, German Health Minister Karl Lauterbach...
Merinda Teller Over the past six decades, solid organ transplantation has gone...

Thank you!

Thank you for your membership application. As soon as your payment has been received your membership will be activated and you will be informed via email.

Thank you.

Thank you!

The form has been submitted successfully!